Serum Cytokine Profiles in Patients with Inflammatory Bowel Disease in Clinical Remission: A Cross-Sectional Comparison by Anti-TNF Therapy
Sara Jarmakiewicz-Czaja, Pawel R Kiela, Dominika Piątek, Aneta Sokal-Dembowska, Joanna Sztembis, Rafał Filip · 2026
Read Serum Cytokine Profiles in Patients with Inflammatory Bowel Disease in Clinical Remission: A Cross-Sectional Comparison by Anti-TNF Therapy by Sara Jarmakiewicz-Czaja, Pawel R Kiela, Dominika Piątek, Aneta Sokal-Dembowska, Joanna Sztembis, Rafał Filip (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13232536.txt.
Description
Sara Jarmakiewicz-Czaja and colleagues measure in 2026 blood immune signals in bowel disease patients whose symptoms had settled. Their group held one hundred thirty-two patients in clinical remission plus twenty-nine healthy controls. Eight cytokines, the signaling proteins that steer inflammation, were compared between patients on anti-TNF biologics and patients on standard drugs.
No clear gap appeared between treatment groups for any of the signals measured. Profiles also separated patients from one another poorly while disease stayed quiet. Blood cytokine levels, the team suggests, do not simply mirror which drug class a patient takes. Longer studies that follow the same patients could show whether these signals warn of relapse or fading drug response.
Catalog record
| CREATOR | Sara Jarmakiewicz-Czaja, Pawel R Kiela, Dominika Piątek, Aneta Sokal-Dembowska, Joanna Sztembis, Rafał Filip |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |